Ionis Pharmaceuticals
Patents, Design & Utilities
Last updated:
List of all Ionis Pharmaceuticals patents 237 in total
| Status | Patent |
|---|---|
Application | Utility: GLP-1 Receptor Ligand Moiety Conjugated Oligonucleotides and Uses Thereof Filling date: 8 Sep 2025 Issue date: 11 Nov 2021 |
Application | Utility: METHODS FOR REDUCING LRRK2 EXPRESSION Filling date: 8 Sep 2025 Issue date: 4 Nov 2021 |
Grant | Utility: Methods for modulating expression of C9ORF72 antisense transcript Filling date: 8 Sep 2025 Issue date: 2 Nov 2021 |
Grant | Utility: Modified compounds and uses thereof Filling date: 8 Sep 2025 Issue date: 19 Oct 2021 |
Application | Utility: Compounds and Methods for Modulation of Transcript Processing Filling date: 8 Sep 2025 Issue date: 14 Oct 2021 |
Grant | Utility: Methods and compositions for inhibiting PMP22 expression Filling date: 8 Sep 2025 Issue date: 5 Oct 2021 |
Grant | Utility: Compositions and methods for modulating MECP2 expression Filling date: 8 Sep 2025 Issue date: 28 Sep 2021 |
Application | Utility: Compounds and Methods for the Modulation of Proteins Filling date: 8 Sep 2025 Issue date: 2 Sep 2021 |
Grant | Utility: Oligomer-conjugate complexes and their use Filling date: 8 Sep 2025 Issue date: 31 Aug 2021 |
Application | Utility: Selective Antisense Compounds and Uses Thereof Filling date: 8 Sep 2025 Issue date: 5 Aug 2021 |
Grant | Utility: Compositions and methods for modulation of IKBKAP splicing Filling date: 8 Sep 2025 Issue date: 20 Jul 2021 |
Application | Utility: COMPOSITIONS FOR MODULATING EXPRESSION OF C9ORF72 ANTISENSE TRANSCRIPT Filling date: 8 Sep 2025 Issue date: 15 Jul 2021 |
Grant | Utility: Methods of treating breast cancer Filling date: 8 Sep 2025 Issue date: 13 Jul 2021 |
Application | Utility: COMPOSITIONS AND METHODS FOR MODULATING GROWTH HORMONE RECEPTOR EXPRESSION Filling date: 8 Sep 2025 Issue date: 8 Jul 2021 |
Grant | Utility: Modulation of prekallikrein (PKK) expression Filling date: 8 Sep 2025 Issue date: 6 Jul 2021 |
Application | Utility: MODULATORS OF ENaC EXPRESSION Filling date: 8 Sep 2025 Issue date: 17 Jun 2021 |
Grant | Utility: Modulation of Lnc05 expression Filling date: 8 Sep 2025 Issue date: 15 Jun 2021 |
Application | Utility: MODULATION OF FACTOR 11 EXPRESSION Filling date: 8 Sep 2025 Issue date: 10 Jun 2021 |
Application | Utility: Conjugated Antisense Compounds for Use in Therapy Filling date: 8 Sep 2025 Issue date: 10 Jun 2021 |
Application | Utility: METHODS FOR REDUCING C9ORF72 EXPRESSION Filling date: 8 Sep 2025 Issue date: 10 Jun 2021 |
Application | Utility: METHODS OF MODULATING ANTISENSE ACTIVITY Filling date: 8 Sep 2025 Issue date: 10 Jun 2021 |
Grant | Utility: Compounds and methods for reducing FXI expression Filling date: 8 Sep 2025 Issue date: 1 Jun 2021 |
Application | Utility: MODULATORS OF EZH2 EXPRESSION Filling date: 8 Sep 2025 Issue date: 27 May 2021 |
Grant | Utility: Allele specific modulators of P23H rhodopsin Filling date: 8 Sep 2025 Issue date: 25 May 2021 |
Application | Utility: Selective Antisense Compounds and Uses Thereof Filling date: 8 Sep 2025 Issue date: 20 May 2021 |
Application | Utility: Oligomeric Compounds Comprising Bicyclic Nucleotides and Uses Thereof Filling date: 8 Sep 2025 Issue date: 20 May 2021 |
Application | Utility: COMPOUNDS AND METHODS FOR REDUCING SPDEF EXPRESSION Filling date: 8 Sep 2025 Issue date: 13 May 2021 |
Application | Utility: MODULATION OF HUNTINGTIN EXPRESSION Filling date: 8 Sep 2025 Issue date: 13 May 2021 |
Grant | Utility: Modulators of PCSK9 expression Filling date: 8 Sep 2025 Issue date: 11 May 2021 |
Application | Utility: COMPOSITIONS AND METHODS Filling date: 8 Sep 2025 Issue date: 6 May 2021 |
Application | Utility: METHODS OF MODULATING ANTISENSE ACTIVITY Filling date: 8 Sep 2025 Issue date: 6 May 2021 |
Application | Utility: MODULATORS OF YAP1 EXPRESSION Filling date: 8 Sep 2025 Issue date: 29 Apr 2021 |
Application | Utility: MODULATION OF TRANSTHYRETIN EXPRESSION Filling date: 8 Sep 2025 Issue date: 1 Apr 2021 |
Grant | Utility: Methods of modulating KEAP1 Filling date: 8 Sep 2025 Issue date: 30 Mar 2021 |
Application | Utility: COMPOUNDS AND METHODS FOR REDUCING FXI EXPRESSION Filling date: 8 Sep 2025 Issue date: 25 Mar 2021 |
Application | Utility: COMPOSITIONS AND METHODS FOR MODULATING APOLIPOPROTEIN (a) EXPRESSION Filling date: 8 Sep 2025 Issue date: 25 Mar 2021 |
Application | Utility: MODULATION OF ALPHA SYNUCLEIN EXPRESSION Filling date: 8 Sep 2025 Issue date: 25 Mar 2021 |
Application | Utility: MODULATION OF FRATAXIN EXPRESSION Filling date: 8 Sep 2025 Issue date: 25 Mar 2021 |
Grant | Utility: Compounds and methods for modulation of dystrophia myotonica-protein kinase (DMPK) expression Filling date: 8 Sep 2025 Issue date: 23 Mar 2021 |
Application | Utility: Modulators of PCSK9 Expression Filling date: 8 Sep 2025 Issue date: 18 Mar 2021 |
Application | Utility: Modulators of APOL1 Expression Filling date: 8 Sep 2025 Issue date: 18 Mar 2021 |
Application | Utility: MODULATORS OF PNPLA3 EXPRESSION Filling date: 8 Sep 2025 Issue date: 18 Mar 2021 |
Application | Utility: ANTISENSE OLIGONUCLEOTIDE COMPOSITIONS Filling date: 8 Sep 2025 Issue date: 18 Mar 2021 |
Grant | Utility: Modulation of androgen receptor expression Filling date: 8 Sep 2025 Issue date: 9 Mar 2021 |
Application | Utility: CONJUGATED ANTISENSE COMPOUNDS AND THEIR USE Filling date: 8 Sep 2025 Issue date: 25 Feb 2021 |
Application | Utility: CONJUGATED ANTISENSE COMPOUNDS AND THEIR USE Filling date: 8 Sep 2025 Issue date: 25 Feb 2021 |
Grant | Utility: Modulators of APOL1 expression Filling date: 8 Sep 2025 Issue date: 23 Feb 2021 |
Grant | Utility: Compositions and methods for modulating apolipoprotein C-III expression Filling date: 8 Sep 2025 Issue date: 23 Feb 2021 |
Application | Utility: COMPOUNDS AND METHODS FOR MODULATING GFAP Filling date: 8 Sep 2025 Issue date: 11 Feb 2021 |
Application | Utility: COMPOUNDS AND METHODS FOR THE MODULATION OF AMYLOID-BETA PRECURSOR PROTEIN Filling date: 8 Sep 2025 Issue date: 11 Feb 2021 |
Showing 50 to 100 of 237 patents.